Cytokinetics | CYTK - EPS Earnings Per Share

Stock Price
62.97
Daily Change
-1.76 -2.72%
Monthly
2.79%
Yearly
24.92%
Q1 Forecast
61.24

Cytokinetics reported $-2.55 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 -1.56 -1.26 Mar/04 2026
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05 2025
FY2025Q2 Jun/2025 -1.12 -1.42 -0.08 Aug/07 2025
FY2025Q1 Mar/2025 -1.36 -1.27 -1.33 May/06 2025
FY2024Q4 Dec/2024 -1.26 -1.22 -1.38 Feb/27 2025




Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Cytokinetics USD -2.55 1.43 Sep/2025
Eisai JPY 36.02 15.33 Sep/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Exelixis USD 0.78 0.03 Sep/2025
Geron USD -0.03 0.01 Sep/2025
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Ligand Pharmaceuticals USD 3.09 1.49 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025